Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest Fresenius Medical Care Stories

2013-06-28 23:19:03

GranuFlo lawsuit involving patients who allegedly suffered heart attacks, cardiac arrest, stroke or sudden cardiac death while undergoing dialysis treatment with recalled NaturaLyte or GranuFlo dialysis drug, both Fresenius products, grows. Dallas, TX (PRWEB) June 28, 2013 A MDL Statistics Report issued on May 14th by the U.S. Judicial Panel on Multidistrict Litigation (JPML) claims that at least 161 Fresenius GranuFlo lawsuit cases have been filed in federal litigation in the district of...

2013-06-27 23:29:33

Resource4thePeople’s national team of attorneys continues offering complimentary consultations for consumers who may have suffered alleged life-threatening side effects from dialysis products. San Diego, CA (PRWEB) June 27, 2013 http://www.resource4thepeople.com/defectivemedicaldevices/Dialysis-Lawsuit.html Resource4thePeople reports today on its latest update to consumers who are following the litigation involving allegations that Fresenius NaturaLyte and GranuFlo kidney dialysis...

2013-06-14 23:02:33

The Firm is investigating GranuFlo lawsuits on behalf of dialysis patients who allegedly experienced cardiac arrest, heart attacks, stroke, sudden cardiac death, or other side effects related to the GranuFlo recall for GranuFlo and NaturaLyte Dialysis Drugs. New York, New York (PRWEB) June 14, 2013 GranuFlo lawsuit claims filed in the wake of last year´s recall for GranuFlo and NaturaLyte dialysis drugs continue to mount in the federal multidistrict litigation now underway in U.S....

2013-05-16 16:25:56

NEW YORK, May 16, 2013 /PRNewswire/ -- American Realty Capital Healthcare Trust II, Inc. ("ARC HT II") announced today that it closed on its first acquisition - a Fresenius dialysis center located in Winfield, Alabama. The purchase price of the property was $1.9 million, exclusive of closing costs. (Logo: http://photos.prnewswire.com/prnh/20130516/NY15739LOGO) The Fresenius dialysis center contain 5,564 rentable square feet and is net leased to a subsidiary of Fresenius Medical Care...

2013-05-14 08:33:44

GLENDALE, Calif. and WALTHAM, Mass., May 14, 2013 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed") (OTCQB: AMEH), a physician-driven integrated health care delivery company and Fresenius Medical Care (NYSE: FMS), North America's largest provider of kidney care services, announced today that ApolloMed's subsidiary, ApolloMed ACO (Accountable Care Organization), is teaming with Fresenius Medical Care to provide integrated health care management for its patients with end stage renal...

2013-05-09 23:43:35

Alert: Granuflo Allegedly Linked to Serious Health Risks Including Stroke, Heart Attack and Cardiopulmonary Arrest. Dallas, TX (PRWEB) May 08, 2013 The National Plaintiff´s Law Firm of Baron and Budd is now handling lawsuits pertaining to the recall of Granuflo, the brand name of a dialysate (http://www.fda.gov/medicaldevices/safety/listofrecalls/ucm309990.htm ). Dialysate is used when a patient undergoes dialysis, a long-term medical treatment used to treat kidney conditions....

2013-05-09 23:30:26

Judge begins organizing numerous lawsuits alleging Fresenius dialysis products were linked to life-threatening heart problems. Resource4thePeople attorneys continue offering free legal consultations for consumers. San Diego, CA (PRWEB) May 09, 2013 http://www.resource4thepeople.com/defectivemedicaldevices/Dialysis-Lawsuit.html Resource4thePeople reports today to consumers that a judge has been assigned to oversee the consolidated federal lawsuits assigned to U.S. District Court in...

2013-05-04 23:01:56

The Firm is now evaluating GranuFlo recall lawsuits on behalf of dialysis patients who experienced cardiac arrest, heart attacks, stroke, sudden cardiac death, or other alleged GranuFlo side effects within 48 hours of a dialysis treatment with GranuFlo or NaturaLyte. New York, New York (PRWEB) May 04, 2013 GranuFlo lawsuits filed in the wake of last year´s recall for GranuFlo and NaturaLyte dialysis concentrates continue to mount in state and federal courts throughout the country,...

2013-04-01 23:03:41

The Firm is offering GranuFlo heart attack lawsuit evaluations to dialysis patients who allegedly experienced cardiac arrest, heart attacks, stroke, sudden cardiac death, or other side effects within 48 hours of a dialysis treatment with GranuFlo or NaturaLyte dialysis concentrates. New York, New York (PRWEB) April 01, 2013 Court documents indicate that a panel of federal judges has agreed to consolidate all GranuFlo lawsuits stemming from the recent recall of GranuFlo or NaturaLyte...

2013-03-15 23:04:10

The Firm is offering GranuFlo recall lawsuit evaluations to dialysis patients who experienced cardiac arrest, heart attacks, stroke, sudden cardiac death, or other side effects within 48 hours of a dialysis treatment with GranuFlo or NaturaLyte dialysis concentrates. New York, New York (PRWEB) March 15, 2013 As GranuFlo lawsuits related to Fresenius´ recent recall of GranuFlo and NaturaLyte dialysis concentrates continue to mount, the company is facing more problems with the U.S. Food...